Author: NLS Informationsmedizin GmbH, Herbert Eder Modern medicine no longer works exclusively with drugs, scalpels and laboratory values. Numerous procedures based on energy, waves, fields and physical stimuli are already being used in clinics today. This is precisely where the bridge to frequency therapy and extended concepts beginsContinue reading

Mebendazole polymorph C for the treatment of brain tumors - what does US patent US 11,110,079 B2 really protect? The US patent US 11,110,079 B2 (granted on September 7, 2021) describes a very specific „repurposing“ approach: The known anthelmintic active ingredient mebendazole is not simply to be used „off-label“, but in a defined crystal form (polymorph C) and in a specific galenic formulation.Continue reading

1 Introduction A blastoma - also known as an embryonal tumor - is a rare cancer that occurs predominantly in children and describes tumors that arise from embryonic or immature cells that were formed during the early development of the body. Depending on the tissue affected, a blastoma can occur in various organs,Continue reading

1. introduction Bladder carcinoma, also known as urothelial carcinoma, is one of the most common types of cancer of the urinary tract.the tumor mainly arises from the urothelial mucosa of the urinary bladder, which lines the inner wall.men are affected about three times as often as women. Risk factors: long-term smoking, contact with aromatic amines (e.g. in dyes), chronic bladder inflammation, radiotherapy, certain medications orContinue reading

1 Introduction Biliary tract carcinoma, also known as cholangiocarcinoma, is a rare but aggressive malignant tumor of the biliary tract. It can develop inside (intrahepatic) or outside (extrahepatic) the liver and usually affects older people, somewhat more frequently men. Risk factors include chronic inflammation of the bile ducts, gallstones, primary sclerosing cholangitis (PSC), parasitic infections (e.g.Continue reading